JMP Securities Increases Option Care Health (NASDAQ:OPCH) Price Target to $37.00

Option Care Health (NASDAQ:OPCH) had its price objective raised by stock analysts at JMP Securities from $36.00 to $37.00 in a report released on Monday, Benzinga reports. The firm currently has a “market outperform” rating on the stock. JMP Securities’ price objective suggests a potential upside of 22.72% from the company’s previous close.

Separately, Barrington Research boosted their price objective on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st.

Option Care Health Trading Down 3.7 %

Shares of OPCH stock opened at $30.15 on Monday. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. The firm has a market cap of $5.24 billion, a P/E ratio of 19.84, a price-to-earnings-growth ratio of 2.42 and a beta of 1.29. The business has a 50-day moving average price of $31.27 and a two-hundred day moving average price of $30.39. Option Care Health has a 12-month low of $26.11 and a 12-month high of $34.63.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The company had revenue of $1.23 billion for the quarter, compared to analysts’ expectations of $1.17 billion. During the same quarter last year, the company earned $0.63 EPS. The firm’s revenue was up 14.8% compared to the same quarter last year. Equities analysts anticipate that Option Care Health will post 1.22 EPS for the current fiscal year.

Insider Activity at Option Care Health

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The sale was disclosed in a filing with the SEC, which is available through this link. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares in the company, valued at $663,429.51. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Aristides Capital LLC bought a new position in Option Care Health in the second quarter worth $241,000. Algert Global LLC increased its stake in shares of Option Care Health by 12.4% in the 2nd quarter. Algert Global LLC now owns 197,797 shares of the company’s stock worth $5,479,000 after acquiring an additional 21,853 shares in the last quarter. Mackenzie Financial Corp lifted its position in Option Care Health by 7.2% during the 2nd quarter. Mackenzie Financial Corp now owns 45,782 shares of the company’s stock valued at $1,268,000 after acquiring an additional 3,070 shares during the period. The Manufacturers Life Insurance Company boosted its stake in Option Care Health by 16.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,759,061 shares of the company’s stock worth $48,726,000 after acquiring an additional 244,876 shares in the last quarter. Finally, Dark Forest Capital Management LP purchased a new stake in Option Care Health in the second quarter worth about $210,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.